# About Peptivio Peptides — An Independent Cognitive & Nootropic Research Desk > About Peptivio Peptides: an independent literature digest on Selank and DSIP, two Cognitive & Nootropic research peptides studied for mood, stress and sleep. How it is compiled, and what it is not. An independent, citation-anchored digest of the nootropic and anxiolytic-peptide research literature. Not a vendor. Not a clinic. Not medical advice. ## What Peptivio Peptides is Peptivio Peptides is an independent editorial reference desk covering the published research on two neuroactive peptides studied in the context of **mood, stress and sleep**: Selank and DSIP, with Selank as the lead. The site exists to make a scattered and frequently overstated literature legible — to tell a reader, in plain language and with citations, what each compound was actually studied for, in which species, and how far that evidence reaches. The organizing theme is *anxiolytic and sleep-oriented peptide research* — specifically, the question of whether short amino-acid chains can modulate the chemistry of anxiety, stress reactivity, and sleep onset in ways that differ meaningfully from classical psychiatric drugs. Both Selank and DSIP are studied in that space, but they represent very different stages of scientific understanding: one with a partially characterized mechanism and limited human clinical data (Selank), one whose mechanism remains genuinely unknown after four decades of research (DSIP). Reading them together gives a realistic picture of how uneven and early this field is. Each compound has its own page; a comparison page lines them up side by side; and a single shared references list aggregates every cited source. ## Editorial method Every claim on this desk is attributed to a numbered citation in the shared references list, and citations are drawn from peer-reviewed journals, formal reviews, and registered clinical studies — not secondary web sources. Where a finding is preclinical (animal or cell-based), that is stated explicitly. Where human data exist, the study size, design, and limitations are described, not glossed. This desk also includes **real-world community reports**, labeled throughout as **"anecdotal, not clinical evidence"** and distinct from the cited research findings. The rationale is straightforward: what users report and what peer-reviewed studies show are different kinds of information, and conflating them is a disservice to the reader; so are pretending community accounts don't exist or ignoring them because they're inconvenient. Honest coverage of a topic like neuroactive research peptides has to include both layers, clearly separated. Where the literature is honest about uncertainty — DSIP's unresolved mechanism, Selank's single-region evidence base, the non-response rate for DSIP — this desk is honest about it too. Uncertainty is part of the record, not an embarrassment to be softened. ## What this desk is not Peptivio Peptides is not a seller, a clinic, a pharmacy, or a prescriber. It does not sell, stock, distribute, or source any compound. It does not recommend any compound for any purpose in any person. It does not list a human dose for any compound on this site — ever. Neither Selank nor DSIP is approved by the FDA, EMA, or any major Western regulator for any indication. Both are sold outside their countries of study as unregulated research chemicals with no pharmaceutical quality, purity, or sterility guarantee. This desk describes research findings; it does not imply that any use of these compounds in human beings is safe, appropriate, or legal in any jurisdiction. If you are experiencing anxiety, insomnia, or any other medical or mental-health condition, please consult a qualified healthcare professional. Nothing on this site is a substitute for that. --- An independent literature digest — curious, citation-grounded, and honest about what the research does and does not establish.